CNTG - RIDE NERV and GNLN among pre-market losers
2023-06-29 08:47:24 ET
- BioXcel Therapeutics ( BTAI ) -67% . announces positive topline results from TRANQUILITY II phase 3 trial of BXCL501 for acute treatment of alzheimer’s disease-related agitation .
- CorMedix ( CRMD ) -21% on pricing $40M securities offering .
- Greenlane Holdings ( GNLN ) -16% .
- Black Diamond Therapeutics ( BDTX ) -13% on $75M stock offering .
- Hitek Global ( HKIT ) -11% .
- Centogene ( CNTG ) -10% .
- Minerva Neurosciences ( NERV ) -10% .
- Beneficient ( BENF ) -7% .
- Lordstown Motors ( RIDE ) -5% .
For further details see:
RIDE, NERV and GNLN among pre-market losers